| Sign In to gain access to subscriptions and/or personal tools. |
Species and Sex Differences in Susceptibility to Olfactory Lesions Among the Mouse, Rat and Monkey Following an Intravenous Injection of Vincristine SulphateDrug Safety Research Laboratory, Daiichi Pharmaceutical Company Ltd., Tokyo 134-8630, Japan Correspondence: Address correspondence to: Kiyonori Kai, Daiichi Pharmaceutical Co. Ltd., Drug Safety Research Laboratory, 1-16-13, Kita-Kasai, Edogawa-ku, Tokyo 134-8630, Japan; e-mail:kaikitrx{at}daiichipharm.co.jp
Species and sex differences in susceptibility to vincristine sulphate (VCR)-induced olfactory epithelial lesions were investigated among the BALB/c mice, Crj: CD(SD) IGS rats and common marmoset monkeys following a single intravenous administration on day 1. As dosage levels, the 0.17-fold LD10, 0.6-fold LD10 and LD10 were used for mice and rats, and a maximum tolerated dose (MTD) was chosen only for monkeys. The order of strength of VCR action on peripheral neuropathic signs, body weight gain, and hematological parameters was mice > rats > monkeys, without clear sex differences. Histopathologically, on day 2, single cell death in the olfactory epithelium and vomeronasal organ was observed only in male mice at LD10, and in female mice at 0.6-fold LD10 or more. On day 5, the olfactory epithelium in these mice showed regenerative proliferation suggesting a sign of recovery. On day 10, axonopathy and demyelination in the sciatic and trigeminal nerves were noted in mice of both sexes at 0.6-fold LD10 or more. In rats and monkeys of either sex, however, no morphological changes were observed at any dose level. In conclusion, mice, particularly females, were shown to be more susceptible to VCR-induced apoptosis in the olfactory epithelium than rats and monkeys.
Key Words: Mice • olfactory lesions • monkeys • rats • vincristine sulphate
Vincristine sulphate (VCR), a vinca alkaloid derivative, is widely used as chemotherapy for the treatment of malignant tumors in humans (Gidding et al., 1999). Although the toxic targets of cancer chemotherapeutic drugs are ordinarily cells or tissues having a high mitotic activity (e.g., lymphohematopoietic tissue, intestine, skin and testis), the dose-limiting toxicity for VCR in humans is neurotoxicity, which includes peripheral, symmetric mixed sensory-motor, and autonomic neuropathy with morphological lesions (axonopathy and secondary demyelination). VCR-induced neurotoxicity has been recognized to be caused by interference with microtubule function resulting in the blockage of axonal transport and thus axonal degeneration (Gidding et al., 1999). In laboratory animals such as mice, rats, and monkeys, neurotoxicity including abnormal behavior and histopathological lesions in the peripheral nerves has been reported to be evoked by repeated or intermittent administration of VCR (Gottschalk et al., 1968; Todd et al., 1976, 1979; Aley et al., 1996; Authier et al., 1999; Topp et al., 2000; Nakamura et al., 2001; Borzan et al., 2004). There had been no reports, however, on VCR-induced olfactory epithelial lesions in experimental animals prior to our description (Kai et al., 2002). We have previously reported about VCR-induced apoptosis in the olfactory epithelium of male mice on days 2 to 5 after a single intravenous injection at a 10% lethal dose (LD10, Kai et al., 2002). In the present investigation, to clarify species and sex differences in susceptibility to the toxicity in the olfactory epithelium, VCR was intravenously injected once on day 1 at 0.17-fold LD10, 0.6-fold LD10 (corresponding to the maximum tolerated dose: MTD) and LD10 to mice and rats of both sexes, and only at an MTD to monkeys of both sexes. Afterward, these animals were serially euthanized on days 2, 5, and 10 for histological examinations.
Animals Sixty-six males and 66 females of BALB/c mice and Crj:CD(SD) IGS rats were purchased from Charles River Japan, Inc. (Atsugi, Japan), and used at 8-week-old (body weight: 20 to 29 g) and 7-week-old (body weight: 173 to 295 g), respectively. Eight male and 8 female common marmoset monkeys purchased from Yaotsu Breeding Laboratory Japan, Inc. (Gifu, Japan) were used at 3- to 5-year-old (body weight: 310 to 470 g). The rodents were housed 3 to 5 animals per wire-mesh cage in air-conditioned rooms (temperature, 23 ± 2°C; relative humidity, 55 ± 15%). The monkeys were individually housed in stainless steel cages in an air-conditioned room (temperature, 24 ± 2°C; relative humidity, 60 ± 20%). A light/dark cycle was 12 h in the animal rooms. Basal diet (F-2 for mice and rats, Funabashi Farm, Chiba, Japan; CMS-1M for monkeys, CLEA Japan, Inc., Tokyo, Japan) and tap water were available ad libitum. All experimental procedures were performed in accordance with the Guidelines for Animal Experimentation issued by the Japanese Association for Laboratory Animal Science (Japanese Association for Laboratory Animal Science, 1987).
Chemicals
Experimental Design
Clinical Investigation Clinical signs were observed immediately after administration and once each on days 2, 5, and 10, body weight was measured on days 1, 2, 5, and 10, and hematology on days 2, 5, and 10. On days 2, 5, and 10, the blood sample was collected from the abdominal vein of mice and monkeys or the jugular vein of rats under ether (mice and rats) or pentobarbital (monkeys) anesthesia. The whole blood was analyzed for reticulocyte (RET), white blood cell (WBC) and platelet (PLT) counts by ADVIA 120 (Bayer Medical, Tokyo, Japan), a total hematology system. The animals of each group were subsequently euthanized by exsanguination for the following examinations.
Light Microscopy
Terminal TdT-Mediated dUTP-Nick-End Labelling (TUNEL) Assay Sections at the level 3 made from mice of the control and VCR 1.95 mg/kg groups, which were euthanized on day 2, were subjected to TUNEL assay. Briefly, the sections were treated with 20 µg/ml proteinase K (SIGMA, Tokyo, Japan) for 15 min at room temperature and then apoptotic DNA fragmentation was marked by using an Apop Tag TM peroxidase In Situ apoptosis detection kit (Intergen Company, Purchase, NY).
Keratin Immunohistochemistry
Electron Microscopy
Statistics
Clinical Investigation Clinical signs, body weights and hematology data are summarized in Table 2. In mice given VCR at a high dose (1.95 mg/kg), decreased locomotor activity, loss of extension reflex in the posterior limbs, and unkempt fur were observed in males and/or females from days 8 to 10, and one male died on day 8. No abnormal signs, however, were seen in rats and monkeys of either sex even at high doses. Body weights were decreased in mice, rats or monkeys of both sexes at the middle dose or more on days 5 and/or 10. This decrease was most severe in mice. Hematological data were shown in Figure 2 (data only from males in each species were represented, since a difference between both sexes was trivial as mentioned next). RET counts were decreased in mice and rats of both sexes at all doses on days 2 and 5, and in monkeys of both sexes on days 5 and 10. These decreases were common at similar degrees in three species. WBC counts were decreased in mice of both sexes and in male rats at all doses on days 2 and/or 5, and in female rats only at the high dose; however, no change was seen in monkeys of either sex. PLT counts were also decreased in mice of both sexes at all doses on days 2, 5, or 10, in male rats at the middle dose or more on days 2 and/or 5 and in female rats only at the high dose on day 5, and in female monkeys on day 10 only. All fluctuations in WBC and PLT counts were seen at similar degrees in mice and male rats, but were weaker in female rats. In monkeys, the decreased PLT was noted only in females. On later sampling day(s), decreases in RET, WBC and PLT counts observed in mice and rats were recovered to the control level.
Macroscopy and Light Microscopy No macroscopic abnormalities were observed around the nostril or nasal cavity after trimming in any of the groups during the experimental period. Histopathological findings are presented in Table 3. On day 2, the olfactory epithelium in the basal layer (Figures 3a, 3b) and sensory cells of the vomeronasal organ (Figures 3c, 3d) revealed slight to moderate single cell death with condensation and fragmentation of nuclei in male mice at 1.95 mg/kg and in female mice at 1.17 mg/kg or more. Only female mice showed increased numbers of mitotic cells at 1.95 mg/kg. Single cell death was mostly seen in the basal to middle layers of the olfactory epithelium adjacent to the respiratory epithelium in the 5th and 6th ethmoturbinals. The olfactory lesion in female mice at 1.95 mg/kg was more severe than that in male mice. On day 5, the olfactory epithelium in male and female mice at 1.95 mg/kg showed a decrease in grade up to "slight" single cell death and increased numbers of mitotic cells. On day 10, axonopathy and/or demyelination in the trigeminal and sciatic nerves were observed in male and female mice at 1.95 and 1.17 mg/kg or more, respectively (Figures 3e, 3f). In rats and monkeys of either sex, no changes were observed in the olfactory epithelium, vomeronasal organs, and trigeminal and sciatic nerves.
TUNEL Assay In mice of both sexes given 1.95 mg/kg, olfactory epithelial cells in the basal to middle layers revealed positive staining for TUNEL on day 2, but fragmented nuclei scarcely show the positive reaction (Figure 4a). No positive reaction was seen in the control group or negative control staining.
Keratin Immunohistochemistry In mice of both sexes control and VCR group receiving 1.95 mg/kg, flattened basal cells located on the basement membrane of the olfactory epithelium and respiratory epithelium exhibited positive reaction to keratin staining (Figure 4b), but not to TUNEL on day 2. Therefore, the flattened basal cells of the epithelium were identified as being horizontal basal cells. No positive reaction was seen in negative control staining.
Electron Microscopy
Species and sex differences in susceptibility to VCR-induced olfactory lesions were investigated among the mice, rats and common marmoset monkeys. Histopathologically, apoptosis was seen in the basal to middle layers of the olfactory epithelium adjacent to the respiratory epithelium only in mice. This apoptosis was limited to sensory cells and their precursor cells (globose basal cells), but it was not seen in keratin-positive horizontal basal cells of the olfactory epithelium. Single cell death was also observed in the vomeronasal organs. In addition, apoptosis was observed in male mice at 1.95 mg/kg and in female mice at 1.17 mg/kg or more, demonstrating higher susceptibility in females than in males; however, no such sex difference was noted for axonopathy and/or demyelination in the trigerminal and sciatic nerves. None of the changes seen in mice were detected in rats and monkeys of either sex. Thus, mice were shown to have high susceptibility to VCR-induced apoptosis in the olfactory epithelial cells and axonopathy in the peripheral nerves or rats and monkeys were resistant to olfactory epithelial lesions including apoptosis. In clinical observations, loss of extension reflex in the posterior limbs was observed on day 8 or later only in mice reflecting the aforementioned axonopathy and demyelination of the sciatic nerves. In humans given weekly intermittent administration of VCR, neurotoxicity was also recognized to be the dose-limiting toxicity (Gidding et al., 1999). A decrease in body weight was strongest in mice among the species employed. Decreases in RET counts were common at similar degrees in mice, rats and monkeys. Decreased WBC and PLT counts were seen at similar degrees in mice and male rats but were stronger in female rats. In monkeys, the decreased PLT was noted only in females. Based on these data, the order (from highest to lowest) of strength of VCR action on peripheral neuropathic signs, body weight gain and hematological parameters was considered to be mice > rats > monkeys without clear sex differences. The most severe days for the appearance of olfactory epithelial lesions, hematotoxicity, and peripheral neuropathy were on day 2, 5, and 10, respectively. The dose for inducing hematotoxicity was lower than that for the peripheral neuropathy under the conditions of this study. In our previous works (Kai et al., 2004, 2005), the tubulin-targeting antitumor agent VCR or paclitaxel, which caused severe apoptosis and/or atrophy in the olfactory epithelium of male mice, had high drug distribution and retention to the lesion site ethmoturbinates, whereas 5-fluorouracil, which showed no lesions in the olfactory epithelium of male mice, scarcely distributed and retained to these sites. This phenomenon was suggestive of evidently being a close implication of olfactory epithelial lesions and drug disposition. Accordingly, one possibility is raised that only a species showing a high drug disposition to the target site would exhibit olfactory lesions. Conversely, according to some reports from other authors (Castle et al., 1976; El Dareer et al., 1977; Krishna et al., 2001), a maximum concentration and half-life of VCR in blood have been proposed to be 0.3 µg/mL and 1.36 h, respectively for female BDF1 mice (body weight: 20 to 23 g) given a single administration of 2 mg/kg; 0.43 µg/mL and 1.5 h for SD rats (body weight: 200 to 250 g) receiving 1 mg/kg; and 0.77 µg/mL and 3.3 h for female rhesus monkeys (body weight: 3.3 to 6.7 kg) dosed with 1 mg/kg. Thus, the blood VCR concentration in rodents was likely to be low rather than that in monkeys. The discrepancy between our data (the magnitude of olfactory epithelial lesions: mice > rats and monkeys) and those of others (the height of blood drug levels: monkeys > rats and mice) may be explained by differences in sites (target tissue versus blood) where the drug level was measured, and experimental conditions such as dosage levels, strain, body weights and injection procedures used. The convert doses (Freireich et al., 1966) in mg/kg to mg/m2 at MTD in each species calculated were 3.51 mg/m2 for mice, 1.26 mg/m2 for rats and 2.1 mg/m2 for monkeys (marmosets). As another possibility, a difference in susceptibility to olfactory epithelial lesions was considered to be due to a difference in mortality. However, overt toxicities were observed in body weights and hematology in all species as mentioned above. Therefore, the species differences in olfactory lesions can not be explained only by the MTD. Alternatively, the further study is necessary to delineate various factors that elicit species differences. Regarding sex difference, only in female mice given the high dose 1.95 mg/kg, increased numbers of mitotic cells were observed in conjunction with severe apoptosis on day 2, and regenerative proliferation of the olfactory epithelium was seen on day 5. The increased mitotic figures in an early time-point (day 2) are thought to imply mitotic arrests, which have been recognized to be an initial event of VCR-induced changes in olfactory epithelial lesions (Kai et al., 2005). On a cellular level, estrogen controls neural proliferation/survival and differentiation, stimulates axonal extension and synapse formation, and influences the physiological function of neural cells (Harlan 1988; Weeks and Levine, 1995; Arai et al., 1996; Beyer and karolczak, 2000). Neurotrophic factors including nerve growth factor, brain-derived neurotrophic factor, glial cell-line derived neutrophic factor and neurotrophin-3 are released from neural cells, and retrogradely transported (soma to axon/terminal) to axons as well as anterograde transport (van Bartheld et al., 2001). In the basal forebrain, estrogen receptors are localized within neurotrophin-sensitive neurons, and estrogen increases the expression of neurotrophins in the cerebral cortex, olfactory bulb and hippocampus (Guthrie and Gall, 1991; Toran-Allerand et al., 1992; Sohrabji et al., 1995; Jezierski and Sohrabji, 2001). Therefore, the higher susceptibility of female mice to the VCR-induced olfactory epithelial apoptosis may be due to higher levels of neurotrophins in the epithelial cells. In conclusion, mice, particularly females, were shown to be more susceptible to VCR-induced apoptosis in the olfactory epithelium than rats and monkeys.
The authors appreciate Dr. M. Kato and Dr. T. Sugawara at the Drug Safety Research Laboratory, Daiichi Pharmaceutical Co., Ltd., for helpful discussion and review of the manuscript. The authors wish to thank Mr. Y. Ozaki, Mr. Y. Ishii and Ms. K. Okado at the Technology Research Center, Daiichi Pharmaceutical Co., Ltd., for their technical assistance of tissue preparation.
Aley, KO, Reichling, DB, & Levine, JD. (1996). Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans. Neuroscience, 73, 259-65[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Arai, Y, Sekine, Y, & Murakami, S. (1996). Estrogen and apoptosis in the developing sexually dimorphic preoptic area in female rats. Neurosci Res, 25, 403-7[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Authier, N, Coudore, F, Eschalier, A, & Fialip, J. (1999). Pain related behaviour during vincristine-induced neuropathy in rats. Neuroreport, 10, 965-8[Web of Science][Medline] [Order article via Infotrieve] Beyer, C, & Karolczak, M. (2000). Estrogenic stimulation of neurite growth in midbrain dopaminergic neurons depends on cAMP/protein kinase A signalling. J Neurosci Res, 59, 107-16[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Borzan, J, LaGraize, SC, & Fuchs, PN. (2004). Effect of chronic vincristine treatment on mechanical withdrawal response and pre-pulse inhibition in the rat. Neurosci Lett, 364, 110-3[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Castle, MC, Margileth, DA, & Oliverio, VT. (1976). Distribution and excretion of (3H) vincristine in the rat and the dog. Cancer Res, 36, 3684-9 El Dareer, SM, White, VM, Chen, FP, Mellet, LB, & Hill, DL. (1977). Distribution and metabolism of vincristine in mice, rats, dogs, and monkeys. Cancer Treat Re, 61, 1269-77 Freireich, EJ, Gehan, EA, Rall, DP, Schmidt, LH, & Skipper, HE. (1966). Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother Rep, 50, 219-44[Medline] [Order article via Infotrieve] Gidding, CE, Kellie, SJ, Kamps, WA, & de Graaf, SS. (1999). Vincristine revisited. Crit Rev Oncol Hematol, 29, 267-87[Web of Science][Medline] [Order article via Infotrieve] Gottschalk, PG, Dyck, PJ, & Kiely, JM. (1968). Vinca alkaloid neuropathy: nerve biopsy studies in rats and in man. Neurolog, 18, 875-82 Guthrie, KM, & Gall, CM. (1991). Differential expression of mRNAs for the NGF family of neurotrophic factors in the adult rat central olfactory system. J Comp Neurol, 313, 95-102[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Harlan, RE. (1988). Regulation of neuropeptide gene expression by steroid hormones. Mol Neurobiol, 2, 183-200[Web of Science][Medline] [Order article via Infotrieve] Japanese Association for Laboratory Animal Science. (1987). Guidelines for animal experimentation. Exp Anim, 3, 285-8 Jezierski, MK, & Sohrabji, F. (2001). Neurotrophin expression in the reproductively senescent forebrain is refractory to estrogen stimulation. Neurobiol Aging, 22, 309-19[Web of Science][Medline] [Order article via Infotrieve] Kai, K, Satoh, H, Kashimoto, Y, Kajimura, T, & Furuhama, K. (2002). Olfactory epithelium as a novel toxic target following an intravenous administration of vincristine to mice. Toxicol Pathol, 30, 306-11 Kai, K, Satoh, H, Kajimura, T, Kato, M, Uchida, K, Yamaguchi, R, Tateyama, S, & Furuhama, K. (2004). Olfactory epithelial lesions induced by various cancer chemotherapeutic agents in mice. Toxicol Pathol, 32, 701-9[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Kai, K, Yoshida, M, Sugawara, T, Kato, M, & Furuhama, K. (2005). Investigation of apoptosis in the murine olfactory epithelium evoked by vincristine sulphate in comparison with that induced by unilateral bulbectomy. The 24th Society of Toxicologic Pathology Annual meeting: Washington, D. C. Krishna, R, Webb, MS, St Onge, G, & Mayer, LD. (2001). Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties. J Pharmacol Exp Ther, 298, 1206-12 Nakamura, Y, Shimizu, H, Nishijima, C, Ueno, M, & Arakawa, Y. (2001). Delayed functional recovery by vincristine after sciatic nerve crush injury: a mouse model of vincristine neurotoxicity. Neurosci Lett, 304, 5-8[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Sohrabji, F, Miranda, RC, & Toran-Allerand, CD. (1995). Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc Natl Acad Sci USA, 92, 11110-4 Suzuki, Y, Takeda, M, Obara, N, & Suzuki, N. (1998). Bulbectomy of neonatal mice induces migration of basal cells from the olfactory epithelium. Brain Res Dev Brain Res, 108, 295-8[CrossRef][Medline] [Order article via Infotrieve] Suzuki, Y, Takeda, M, Obara, N, Suzuki, N, & Takeichi, N. (2000). Olfactory epithelium consisting of supporting cells and horizontal basal cells in the posterior nasal cavity of mice. Cell Tissue Res, 299, 313-25[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Todd, GC, Gibson, WR, & Morton, DM. (1976). Toxicology of vindesine (desacetyl vinblastine amide) in mice, rats, and dogs. J Toxicol Environ Health, 1, 843-50[Web of Science][Medline] [Order article via Infotrieve] Todd, GC, Griffing, WJ, Gibson, WR, & Morton, DM. (1979). Animal models for the comparative assessment of neurotoxicity following repeated administration of vinca alkaloids. Cancer Treat Rep, 63, 35-41[Web of Science][Medline] [Order article via Infotrieve] Topp, KS, Tanner, KD, & Levine, JD. (2000). Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine-induced painful peripheral neuropathy in the rat. J Comp Neurol, 424, 563-76[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Toran-Allerand, CD, Miranda, RC, Bentham, WD, Sohrabji, F, Brown, TJ, Hochberg, RB, & MacLusky, NJ. (1992). Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA, 89, 4668-72 Von Bartheld, CS, Wang, X, & Butowt, R. (2001). Anterograde axonal transport, transcytosis, and recycling of neurotrophic factors: the concept of trophic currencies in neural networks. Mol Neurobiol, 24, 1-28[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Weeks, JC, & Levine, RB. (1995). Steroid hormone effects on neurons subserving behavior. Curr Opin Neurobiol, 5, 809-15[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
Toxicologic Pathology, Vol. 34, No. 3,
223-231 (2006) This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
|
 |
|
Sign In to gain access to subscriptions and/or personal tools.
Top
Abstract
Introduction
